Company
Headquarters: Castel San Pietro, Switzerland
Employees: 1,246
CHF2.12 Billion
CHF as of Jan. 1, 2025
US$2.34 Billion
Company | Market Cap (USD) |
---|---|
Abbott | $213.72 B |
Stryker | $150.01 B |
Boston Scientific Corporation | $149.80 B |
Medtronic | $114.44 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Medacta Group SA develops, manufactures, and distributes orthopedic and spinal surgery medical devices in Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Last Financial Reports Date | Dec. 31, 2023 |
Revenue TTM | CHF506.8 M |
EBITDA | CHF121.7 M |
Gross Profit TTM | CHF347.8 M |
Profit Margin | 10.33% |
Operating Margin | 15.78% |
Quarterly Revenue Growth | 13.10% |
Medacta Group SA has the following listings and related stock indices.
Stock: SIX: MOVE wb_incandescent